in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Cambrex appoints former Teva CEO as board vice chairman
6:53 AM MST | November 29, 2012 | Deepti Ramesh
Cambrex (East Rutherford, NJ) says it has appointed Shlomo Yanai to its board of directors and will serve as its non-executive vice chairman. Yanai was the president and CEO of Teva Pharmaceutical Industries (Petach Tikva, Israel), the largest generic pharmaceutical manufacturer in the world, until his retirement in mid-2012. As vice chairman of the Cambrex board, he will work closely with the company's other directors and its leadership team to formulate and help execute Cambrex's growth strategies, the company says. “Shlomo's outstanding background...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee